Sign Up Today and Learn More About Juvena Therapeutics Stock
Invest in or calculate the value of your shares in Juvena Therapeutics or other pre-IPO companies through EquityZen's platform.
Juvena Therapeutics Stock (JUTH)
Juvena Therapeutics is a biopharmaceutical platform which is discovering novel protein-based therapeutics.
About Juvena Therapeutics Stock
Founded
2017
Headquarters
Palo Alto, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Juvena Therapeutics Press Mentions
Stay in the know about the latest news on Juvena Therapeutics
Igf2 fusion protein formulations and therapeutic uses thereof
patents • May 04, 2025
Regenerative Polypeptides and Uses Thereof
patents • May 04, 2025
Regenerative polypeptides and uses thereof
patents • Feb 08, 2025
Hanadie Yousef on LinkedIn: I'll be at BIO 2024 - join me!
linkedin • Jul 05, 2024
Juvena Therapeutics on LinkedIn: Our CEO, Dr. Hanadie Yousef had a wonderful time at our major investor and…
linkedin • Jul 05, 2024
Juvena Therapeutics Management
Leadership team at Juvena Therapeutics
CSO and Co-Founder
Jeremy O'Connell
CEO and Co-Founder
Hanadie Yousef
Join now and verify your accreditation status to gain access to:
- Juvena Therapeutics Current Valuation
- Juvena Therapeutics Stock Price
- Juvena Therapeutics Management
- Available deals in Juvena Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Juvena Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Juvena Therapeutics Revenue and Financials
- Juvena Therapeutics Highlights
- Juvena Therapeutics Business Model
- Juvena Therapeutics Risk Factors
- Juvena Therapeutics Research Report from SACRA Research
Trading Juvena Therapeutics Stock
How to invest in Juvena Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Juvena Therapeutics through EquityZen funds. These investments are made available by existing Juvena Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Juvena Therapeutics stock?
Shareholders can sell their Juvena Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
